Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • Bitcoin USD

    63,505.90
    -34.27 (-0.05%)
     
  • CMC Crypto 200

    1,368.79
    +56.17 (+4.28%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • Dow

    37,986.40
    +211.02 (+0.56%)
     
  • Nasdaq

    15,282.01
    -319.49 (-2.05%)
     
  • Gold

    2,406.70
    +8.70 (+0.36%)
     
  • Crude Oil

    83.24
    +0.51 (+0.62%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report By Component, By Modality, By Patient Type, By Application, By Region And Segment Forecasts, 2021 - 2028

Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report By Component (Oxygenator, Pumps), By Modality, By Patient Type, By Application, By Region, And Segment Forecasts, 2021 - 2028

New York, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report By Component, By Modality, By Patient Type, By Application, By Region And Segment Forecasts, 2021 - 2028" - https://www.reportlinker.com/p06020583/?utm_source=GNW

Extracorporeal Membrane Oxygenation Machine Market Growth & Trends

The global extracorporeal membrane oxygenation machine market size is expected to reach USD 398.6 million by 2028. It is expected to expand at a CAGR of 5.1% from 2021 to 2028. The market is primarily driven by the increasing incidence of cardiopulmonary and respiratory diseases and technological advancement in the field of ECMO procedures. Cardiovascular disease is one of the leading causes of death globally.

According to the WHO, 17.9 million people died from cardiovascular diseases in 2016. In addition, according to the Extracorporeal Life Support Organization, a total of 45,035 patients globally suffered from respiratory illnesses in 2016. Furthermore, increasing awareness about ECMO procedures, coupled with various government initiatives, is further propelling the growth.

The increasing survival rate of ECMO machine supported surgery for cardiac and respiratory patients is also augmenting the market growth.Applications of ECMO machine procedures have been increased over the years.

ECMO machine was traditionally used in cases of circulatory or respiratory failure. Its applications have expanded to use as rescue therapy for post-organ transplantation and sepsis and in cases of heart failure.

The ECMO machine use has been rising gradually worldwide owing to its benefits such as artificial lung for the patients and growing awareness about its use.Moreover, increasing healthcare expenditure by government and private agencies in order to improve healthcare facilities is adding growth to the market.

According to the American Heart Association, medical expenditure related to CVDs is expected to reach USD 960 billion by 2030 from USD 320 billion in 2011. Major players in the market are focusing on technological collaboration and product launches.

Extracorporeal Membrane Oxygenation Machine Market Report Highlights
• North America accounted for the largest share in 2020 owing to favorable reimbursement policies, the presence of key players, and government initiatives
• By component, the oxygenator segment accounted for the largest share in 2020 owing to its high cost and usage
• In terms of modality, the veno-arterial segment accounted for the largest share in 2020 and is expected to grow at the fastest rate during the forecast period
• Based on patient type, the adult segment is expected to grow at a rapid pace during the forecast period owing to the rising incidence of cardiac and pulmonary diseases
• On the basis of application, the respiratory segment held the largest market share in 2020 and is expected to grow at the fastest rate over the forecast period
Read the full report: https://www.reportlinker.com/p06020583/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001